|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 0.5200 SEK | +1.96% |
|
-7.47% | -83.83% |
| 10-12 | Redeye sees potential path forward for Ascelia after FDA update | FW |
| 10-12 | Ascelia Pharma AB - Special Call |
| Market Cap | 68.1M 6.86M 6.13M 5.66M 5.13M 9.6M 651M 9.75M 26.96M 341M 25.75M 25.2M 1.08B | P/E 2026 * |
-5.67x | P/E 2027 * | 34x |
|---|---|---|---|---|---|
| Enterprise Value | 13.6M 1.37M 1.22M 1.13M 1.02M 1.92M 130M 1.95M 5.39M 68.15M 5.14M 5.03M 215M | EV / Sales 2026 * |
0.52x | EV / Sales 2027 * | 0.46x |
| Free-Float |
90.47% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| ACE | Delayed | |
CBOE
| Real-time | ||
|
CBOE
| Real-time | ||
|
CBOE
| ACEs | Real-time | |
|
Deutsche Boerse AG
| 7ZA | Delayed |
Last Transcript: Ascelia Pharma AB
| 1 day | +2.55% | ||
| 1 week | -7.47% | ||
| Current month | -34.34% | ||
| 1 month | -16.13% | ||
| 3 months | +2.16% | ||
| 6 months | -83.88% | ||
| Current year | -83.83% |
| 1 week | 0.5 |  | 0.64 |
| 1 month | 0.5 | | 1.06 |
| Current year | 0.46 | | 3.55 |
| 1 year | 0.46 | | 3.55 |
| 3 years | 0.46 | | 17.98 |
| 5 years | 0.46 | | 32.9 |
| 10 years | 0.46 | | 66.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 2013-12-31 | |
| Chief Operating Officer | 42 | 2025-10-31 | |
Carin Linde
CTO | Chief Tech/Sci/R&D Officer | 54 | 2018-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 71 | 2017-05-31 | |
| Director/Board Member | 61 | 2016-12-31 | |
Hans Maier
BRD | Director/Board Member | 71 | 2016-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/23/25 | Buy | Chairman | 15,000 | 0.0156% | ||
| 9/23/25 | Buy | Chairman | 8,000 | 0.0083% | ||
| 9/3/24 | Sell | Chief Executive Officer | 112,645 | 0.3337% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.96% | -7.47% | -82.70% | -83.85% | 6.87M | |
| +2.41% | -6.33% | +43.43% | +71.02% | 63.29B | |
| -0.15% | +7.50% | +11.01% | +73.48% | 54.89B | |
| +0.57% | +4.60% | +10.07% | +92.86% | 53.28B | |
| -0.14% | +4.17% | +26.43% | +51.35% | 45.81B | |
| -1.37% | +2.15% | +21.60% | +123.43% | 43.46B | |
| +0.48% | +5.91% | +252.68% | +926.80% | 40.23B | |
| +0.05% | +6.75% | +14.48% | +56.75% | 33.45B | |
| +1.19% | -5.84% | +27.86% | -0.65% | 23.7B | |
| -0.38% | +5.68% | +36.43% | +27.54% | 23.76B | |
| Average | +0.51% | -0.23% | +36.13% | +133.87% | 38.19B | |
| Weighted average by Cap. | +0.38% | +0.55% | +47.70% | +159.77% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 26M 2.62M 2.34M 2.16M 1.96M 3.66M 249M 3.72M 10.29M 130M 9.83M 9.62M 411M | 25M 2.52M 2.25M 2.08M 1.88M 3.52M 239M 3.58M 9.9M 125M 9.45M 9.25M 395M |
| Net income | -11.5M -1.16M -1.03M -956K -866K -1.62M -110M -1.65M -4.55M -57.62M -4.35M -4.26M -182M | 2M 201K 180K 166K 151K 282K 19.12M 286K 792K 10.02M 756K 740K 31.59M |
| Net Debt | -54.5M -5.49M -4.9M -4.53M -4.1M -7.68M -521M -7.81M -21.58M -273M -20.6M -20.17M -861M | -56.5M -5.69M -5.08M -4.7M -4.25M -7.96M -540M -8.09M -22.37M -283M -21.36M -20.91M -892M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-23 | SEK 0.5200 | +1.96% | 183,968 |
| 26-10-22 | SEK 0.5100 | +0.79% | 605,303 |
| 26-10-21 | SEK 0.5060 | -2.32% | 480,174 |
| 26-10-20 | SEK 0.5180 | -3.18% | 460,192 |
| 26-10-19 | SEK 0.5350 | -4.80% | 1,089,454 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACE Stock
Select your edition
All financial news and data tailored to specific country editions
